Stocks-2 News

Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

DiffuSphere™ is designed to enable precise drug delivery at therapeutic dose levels directly into target tissues, enhancing efficacy while minimizing systemic drug levels to optimize safety In clinical trials, a single administration of DiffuSphere™ successfully delivered fluticasone propionate for at least six months in patients with eosinophilic esophagitis or osteoarthritis DiffuSphere™ has shown its versatility with various drug classes, supporting the possibility to treat multiple types of pain, infectious diseases, eye diseases and cancers VICTORIA, BC , Nov. 20, 2024 /PRNewswire/ - Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (NASDAQ: EPRX) (TSX: EPRX), a clinical-stage biotechnology company, today unveiled new pharmacokinetic ("PK") data from its Phase 2a Eosinophilic Esophagitis ("EoE") program. Management believes these data underscore the unique capabilities of Eupraxia's proprietary DiffuSphere™ platform technology, which aims to provide precise, localized, safe, and effective long-lasting drug delivery.

Standard Uranium Announces Financing for up to $1.6 Million

Vancouver, British Columbia--(Newsfile Corp. - November 20, 2024) - Standard Uranium Ltd. (TSXV: STND) (OTCQB: STTDF) (FSE: 9SU0) ("Standard Uranium" or the "Company") is pleased to announce that it will conduct a non-brokered private placement (the "Offering") to raise gross proceeds of up to $1,600,000.

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Deep Pipeline of GPCR Programs Focused Initially on Indications in Endocrinology, Immunology and Inflammation, and Metabolic Diseases

BioStem Technologies Signs Letter of Intent to Acquire Wound Care Products and Technologies from ProgenaCare Global

POMPANO BEACH, Fla., Nov. 20, 2024 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacture, and commercialization of placental-derived biologics, today announced the signing of a Letter of Intent (LOI) to acquire commercial-stage products and development technologies from ProgenaCare Global LLC (“ProgenaCare”), a pioneering medical device company leveraging cutting-edge advances in biomaterials to provide effective, affordable advanced wound care solutions.

Plurilock Announces Dates for Q3 2024 Financial Results and Webinar

Plurilock will host a webinar and live Q&A Tuesday November 26, 2024 at 4:30 pm ET Vancouver, British Columbia--(Newsfile Corp. - November 20, 2024) - Plurilock Security Inc. (TSXV: PLUR) (OTCQB: PLCKF) ("Plurilock" or the "Company"), a global cybersecurity services and solutions provider, announces that it plans to release its financial results for the three and nine-months ended September 30, 2024 after market close on Tuesday, November 26, 2024. Plurilock CEO Ian L.

Spire Reports Fiscal 2024 Results

Affirms long-term growth target; issues fiscal 2025 earnings guidance ST. LOUIS , Nov. 20, 2024 /PRNewswire/ -- Spire Inc. (NYSE: SR) today reported results for its fiscal year 2024 ended September 30.

RYVYL Amends MOU to Adjust Timing of First Tranche Payment to Investor to Retire 8% Senior Convertible Note and Series B Convertible Preferred Stock

SAN DIEGO, CA, Nov. 20, 2024 (GLOBE NEWSWIRE) -- RYVYL Inc. (NASDAQ: RVYL) ("RYVYL" or the "Company"), a leading innovator of payment transaction solutions leveraging proprietary blockchain ledger and electronic payment technology for diverse international markets, amended the previously announced non-binding Memorandum of Understanding (the “MOU”) for the full repayment and termination of an 8% Senior Convertible Note (the “Note) and the redemption of all shares of the Company's Series B Convertible Preferred Stock (the “Preferred Stock”). The MOU has been amended to extend the first tranche payment of $12.8 million to November 29, 2024.

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

SALT LAKE CITY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- The business combination of two AI-powered drug discovery and development companies, Recursion (Nasdaq: RXRX) and Exscientia has been completed, with Exscientia becoming a wholly owned subsidiary of Recursion creating a vertically-integrated and technology-enabled drug discovery platform. Exscientia ADSs (Nasdaq: EXAI) ceased trading and will be delisted from Nasdaq.

BIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCES

MINNEAPOLIS , Nov. 20, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities today announced a partnership with Leader Life Sciences. Under the agreement, Leader Life Sciences becomes a distributor of Bio-Techne's portfolio across the Gulf Cooperation Council (GCC) countries, which include Bahrain, Oman, Qatar, Saudi Arabia, and United Arab Emirates.

Minera Alamos Announces C$8.5 Million Bought Deal Private Placement of Common Shares

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Minera Alamos Inc. (TSXV: MAI; OTCQX: MAIFF) (“Minera Alamos” or the “Company”) is pleased to announce that it has entered into an agreement with National Bank Financial Inc. (“NBF”) as lead underwriter and bookrunner, and on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to which the Underwriters will purchase 28,333,000 common shares (the “Shares”) of the Company at a price of C$0.30 (the “Offering Price”) per Common Share, on a “bought deal” private placement basis, with a right to arrange for substituted purchasers, pursuant to the listed issuer financing exemption (“LIFE”), for aggregate gross proceeds to the Company of approximately C$8.5 million (the “Offering”). The Company has also granted NBF an option exercisable at any time up to 48 hours prior to the closing of the Offering, to purchase for placement up to an additional 5,000,000 Shares at the Offering Price, for additional gross proceeds of up to C$1.5 million.

Harfang Confirms and Expands High-Grade Gold Footprint at Serpent, Québec

MONTREAL, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (“Harfang” or the “Company”) (TSX.V: HAR) is pleased to report additional high-grade gold results from its fall channel sampling program along the Nusa Trend at its wholly-owned Serpent Property (the “Property”) in Eeyou Istchee James Bay, Québec (Figure 1). These results confirm and expand the high-grade gold footprint identified during the summer 2024 exploration program and further reinforces the prospectivity of the recently defined Nusa Trend and the entire Serpent Property.

Willis Sustainable Fuels (UK) Limited Enters into Master Services Agreement with McDermott

Key Milestone in Development of Advanced Sustainable Aviation Fuel (SAF) Facility in the UK Key Milestone in Development of Advanced Sustainable Aviation Fuel (SAF) Facility in the UK

CONNEXA RECEIVES NASDAQ APPROVAL TO ACQUIRE YUANYU ENTERPRISE MANAGEMENT

Windsor Mills, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (Nasdaq:YYAI) is pleased to announce that it has received Nasdaq approval for its continued listing following the acquisition of a further 50% ownership stake in Yuanyu Enterprise Management Limited (YYEM), a Hong Kong-based entity focused on the global Love and Marriage sector. As already approved by Connexa's shareholders, upon completion of this acquisition Connexa will undergo a change of control, appoint new directors and effect a spin-off of the Slinger Bag business.

S&P 500 bounces as stocks' bull-market cycle seen potentially speeding up in 2025

The S&P 500 has bounced from its drop last week, a decline that had eroded its U.S. election bump without knocking the index off course toward a potentially big 2024 gain.

Solaris Announces Final Steps to Complete Emigration by Year-End, Including Management and Board Changes; Growth-Oriented Spin-out Anticipated in 2025

QUITO, Ecuador, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) is pleased to announce the final steps to complete its emigration by year-end following the Company's previous announcement to position the Company to maximize returns for shareholders and protect the interests of stakeholders by aligning with regulators in Ecuador as Warintza completes the permitting process (see the Company's news release dated September 9, 2024).

Global-e Reports Third Quarter 2024 Results

PETAH-TIKVA, Israel, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Global-e Online Ltd. (Nasdaq: GLBE) the leader of global Direct-To-Consumer eCommerce enablement, today reported financial results for the third quarter of 2024.

CeriBell: Healthcare Technology Stock With A Promising Growth Outlook

Initiating coverage on CeriBell with a "Buy" rating, citing a promising growth outlook and a 24-month investment horizon. CeriBell's Ceribell System, an AI-powered EEG platform, shows strong revenue growth and high gross margins, indicating robust cash flow potential. The company targets a $2 billion addressable market, with plans for geographic expansion and diversification into other neurological conditions like delirium and ischemic stroke.

ZIM Reports Financial Results for the Third Quarter of 2024; Raises Full Year 2024 Guidance

Reported Revenues of $2.77 Billion, Net Income of $1.13 Billion, Adjusted EBITDA 1  of $1.53 Billion and Adjusted EBIT of $1.24 Billion 2 ; Achieved Adjusted EBITDA and Adjusted EBIT Margins of 55% and 45%, Respectively Achieved 12% Volume Growth YOY with Record Carried Volume of 970 Thousand TEUs in Q3 2024 Increased Full Year 2024 Guidance to Adjusted EBITDA of $3.3 Billion to $3.6 Billion and Adjusted EBIT of $2.15 Billion to $2.45 Billion 3 Declared Increased Dividend of ~$440 million, Comprised of a Regular Dividend of ~$340 Million, or 30% of Q3 Net Income, Plus Special Dividend of ~$100 Million; Per Share Distribution: $3.65 Per Share, Reflecting Regular Dividend of $2.81 Per Share Plus Special Dividend of $0.84 Per Share HAIFA, Israel , Nov. 20, 2024 /PRNewswire/ -- ZIM Integrated Shipping Services Ltd. (NYSE: ZIM), ("ZIM" or the "Company") a global container liner shipping company, announced today its consolidated results for the three and nine months ended September 30, 2024.

VitalHub announces SHREWD implementation with Winnipeg Regional Health Authority

TORONTO, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Vitalhub Corp. (TSX: VHI) (OTCQX: VHIBF) (the “Company” or “VitalHub”) is pleased to announce that it has successfully completed an implementation of its regional patient flow and whole-system visibility platform, SHREWD, to support improved patient flow and safer, more effective care coordination.

IREN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Iris Energy Limited Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / November 20, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Iris Energy Limited ("Iris Energy" or "the Company") (NASDAQ:IREN) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Iris Energy securities between June 20, 2023, and July 11, 2024, inclusive (the "Class Period").

Next